Pharmaceutical Care and Quality of Life in Conditions Related to Psychotropic Drug Use

This study aims to assess and describe the impact of pharmaceutical care on identified drug-related problems (DRPs) in subjects using psycholeptics and psychoanaleptics in primary care, improving subjects' self-assessed quality of life (QoL) The hypothesis of the study are: 1. Side-effects are the most common DRPs in subjects using psychotropic medicines in primary care, 2. Treatment effectiveness and safety affect the subjects´ QoL

NCT Number	NCT06889636
Lead Sponsor	University of Rijeka
Conditions	Mental Health Services
Enrollment	97 participants
Start Date	2021-12-01
Primary Completion	2025-02-14 (estimated)
Study Completion	2025-04 (estimated)
Updated on ClinicalTrials.gov	2025-03-21